Class 2 Medicines Recall: Pfizer Limited, Oxbryta 500mg Tablets (voxelotor), El(24)a/44
Oxbryta 500mg Tablets Recall Summary Pfizer is recalling all batches of Oxbryta 500mg tablets (a medicine used to treat sickle cell disease) that have been distributed in the United Kingdom. The recall is happening because new data from clinical trials and studies has raised concerns about the medicine's safety or effectiveness. This recall affects anyone in the UK who has been prescribed or dispensed this medication.
- Product
- Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies.
- Reason
- Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2024-09-30
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/bc4af352-15af-4c6b-841b-9e77496f5039